Hangming Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hangming Dong has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Cuiping Ye
Nanfang hospital, Guangzhou (Guangdong), China
2 shared publicationsJianhui Xu
Department of Respiratory and Critical Care Medicine, The Zengcheng Branch of Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publicationsJinming Zhang
Nanfang hospital, Guangzhou (Guangdong), China
2 shared publicationsShaoxi Cai
Nanfang hospital, Guangzhou (Guangdong), China
2 shared publications- Shaoxi Cai
Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2 shared publications Shuhua Zhang
Department of Respiratory and Critical Care Medicine, The Zengcheng Branch of Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 20 June 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1538109
Microbial and clinical disparities in pneumonia: insights from metagenomic next-generation sequencing in patients with community-acquired and severe pneumonia
Background: Community-acquired pneumonia (CAP) is a major global cause of death, with its varying symptoms and severity complicating diagnosis and treatment. Severe pneumonia (SP), a more critical form of CAP, has higher mortality and often requires intensive care. The identification of clinical markers to differentiate CAP from SP has the potential to improve treatment protocols and patient outcomes. Concurrently, metagenomic next-generation sequencing (mNGS) demonstrates significant promise in pathogen detection and in elucidating microbiome disparities between CAP and SP.Methods: This retrospective study analyzed clinical and pathogen data from 204 patients diagnosed with CAP and 25 patients diagnosed with SP in the Department of Respiratory and Critical Care Medicine at the Zengcheng Branch of Nanfang Hospital, Southern Medical University, spanning the period from September 2022 to June 2023. Clinical characteristics were compared, and bronchoalveolar lavage fluid (BALF) samples underwent mNGS for microbial detection and characterization. Statistical analyses, encompassing Chi-square, Fisher’s exact test, Student’s t-test, and LEfSe analysis, were employed to compare clinical and microbiological data between the CAP and SP cohorts.Results: Patients with SP were significantly older and exhibited higher incidences of sepsis, hypotension, tachycardia, multilobar infiltrates, and consciousness disorders compared to those with CAP. Elevated levels of C-reactive protein (CRP) and procalcitonin (PCT) were more frequently observed in SP patients. mNGS analysis identified diagnostic microbiology profiles between groups. Diverse microbiological profiles (> 5 species) were more common in SP patients (> 30% detection rate). Beta diversity analysis demonstrated significant differences in microbial community composition between CAP and SP groups (p = 0.001), though alpha diversity metrics showed no significant differences. Both LEfSe and ANCOM-BC2 analyses consistently identified Pseudomonas as a potential biomarker for SP and Streptococcus for CAP.Conclusion: The substantial differences observed in clinical characteristics, pathogen profiles, and microbiomes between patients with CAP and those with SP highlight the imperative need for comprehensive diagnostic methodologies in the management of pneumonia. mNGS has demonstrated substantial utility in informing personalized treatment strategies, with the potential to enhance clinical outcomes. Future research should prioritize elucidating the dynamics of microbial communities and their impact on pneumonia severity, with the objective of refining and optimizing therapeutic strategies.
- 20 June 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1538109
Open AccessMicrobial and clinical disparities in pneumonia: insights from metagenomic next-generation sequencing in patients with community-acquired and severe pneumonia
Background: Community-acquired pneumonia (CAP) is a major global cause of death, with its varying symptoms and severity complicating diagnosis and treatment. Severe pneumonia (SP), a more critical form of CAP, has higher mortality and often requires intensive care. The identification of clinical markers to differentiate CAP from SP has the potential to improve treatment protocols and patient outcomes. Concurrently, metagenomic next-generation sequencing (mNGS) demonstrates significant promise in pathogen detection and in elucidating microbiome disparities between CAP and SP.Methods: This retrospective study analyzed clinical and pathogen data from 204 patients diagnosed with CAP and 25 patients diagnosed with SP in the Department of Respiratory and Critical Care Medicine at the Zengcheng Branch of Nanfang Hospital, Southern Medical University, spanning the period from September 2022 to June 2023. Clinical characteristics were compared, and bronchoalveolar lavage fluid (BALF) samples underwent mNGS for microbial detection and characterization. Statistical analyses, encompassing Chi-square, Fisher’s exact test, Student’s t-test, and LEfSe analysis, were employed to compare clinical and microbiological data between the CAP and SP cohorts.Results: Patients with SP were significantly older and exhibited higher incidences of sepsis, hypotension, tachycardia, multilobar infiltrates, and consciousness disorders compared to those with CAP. Elevated levels of C-reactive protein (CRP) and procalcitonin (PCT) were more frequently observed in SP patients. mNGS analysis identified diagnostic microbiology profiles between groups. Diverse microbiological profiles (> 5 species) were more common in SP patients (> 30% detection rate). Beta diversity analysis demonstrated significant differences in microbial community composition between CAP and SP groups (p = 0.001), though alpha diversity metrics showed no significant differences. Both LEfSe and ANCOM-BC2 analyses consistently identified Pseudomonas as a potential biomarker for SP and Streptococcus for CAP.Conclusion: The substantial differences observed in clinical characteristics, pathogen profiles, and microbiomes between patients with CAP and those with SP highlight the imperative need for comprehensive diagnostic methodologies in the management of pneumonia. mNGS has demonstrated substantial utility in informing personalized treatment strategies, with the potential to enhance clinical outcomes. Future research should prioritize elucidating the dynamics of microbial communities and their impact on pneumonia severity, with the objective of refining and optimizing therapeutic strategies.
- Open Access
- 1 January 2023
- Published by Discovery Medicine in Discovery Medicine
- Vol. 35 (176) , 332-342
Comparison of Third-Generation Sequencing Technology and Traditional Microbiological Detection in Pathogen Diagnosis of Lower Respiratory Tract Infection
Background: It is common to obtain a low detection rate and unsatisfactory detection results in complex infection or rare pathogen detection. This retrospective study aimed to illustrate the application value and prospect of the third-generation sequencing technology in lower respiratory tract infection disease. Methods: This study recruited 70 patients with lower respiratory tract infection (LRTI). Pathogen detection of bronchoalveolar lavage fluid (BALF) from all patients was performed using nanopore metagenomic sequencing technology and traditional culture. BALF culture combined with quantitiative PCR (qPCR) was used as a reference standard to analyze the sensitivity and specificity of nanopore sequencing technology. The current study also collected the examination results of enrolled samples using technical methods sputum culture, tuberculosis DNA (TB-DNA), and Xpert MTB/RIF and analyzed the detection efficiency of nanopore sequencing for Mycobacterium tuberculosis. Results: The positive rates of pathogens in 70 BALF samples detected by conventional culture and nanopore sequencing were 25.71% and 84.29%, respectively. Among the 59 positive BALF cases using nanopore sequencing, a total of 31 pathogens were identified, of which the proportions of bacteria, fungi, viruses, and other pathogens were 50%, 17%, 32%, and 1%, respectively. Using the results combined with culture and qPCR detection methods as the standard, the pathogen detection of BALF using nanopore sequencing had a sensitivity of 70% and a specificity of 91.7%. Additionally, the positive rate of the detection of M. tuberculosis using nanopore sequencing was 33.3% (6/18). The clinical medication plans of 74.3% (52/70) of the patients were referred to the nanopore sequencing results, of which 31 cases changed their treatment strategy, 21 supported the previous treatment plans, and 90% (47/52) of the patients finally had clinical improvement. Conclusions: BALF detection using nanopore sequencing technology improves the process of detecting pathogens in patients with LRTI, especially for M. tuberculosis, fungi, and viruses, by reducing the report time from three days to six hours. The clinical application prospect of nanopore sequencing technology is promising in the pathogen diagnosis of LRTI.
- 1 January 2023
- Published by Discovery Medicine in Discovery Medicine
- Vol. 35 (176) , 332-342
Open AccessComparison of Third-Generation Sequencing Technology and Traditional Microbiological Detection in Pathogen Diagnosis of Lower Respiratory Tract Infection
Background: It is common to obtain a low detection rate and unsatisfactory detection results in complex infection or rare pathogen detection. This retrospective study aimed to illustrate the application value and prospect of the third-generation sequencing technology in lower respiratory tract infection disease. Methods: This study recruited 70 patients with lower respiratory tract infection (LRTI). Pathogen detection of bronchoalveolar lavage fluid (BALF) from all patients was performed using nanopore metagenomic sequencing technology and traditional culture. BALF culture combined with quantitiative PCR (qPCR) was used as a reference standard to analyze the sensitivity and specificity of nanopore sequencing technology. The current study also collected the examination results of enrolled samples using technical methods sputum culture, tuberculosis DNA (TB-DNA), and Xpert MTB/RIF and analyzed the detection efficiency of nanopore sequencing for Mycobacterium tuberculosis. Results: The positive rates of pathogens in 70 BALF samples detected by conventional culture and nanopore sequencing were 25.71% and 84.29%, respectively. Among the 59 positive BALF cases using nanopore sequencing, a total of 31 pathogens were identified, of which the proportions of bacteria, fungi, viruses, and other pathogens were 50%, 17%, 32%, and 1%, respectively. Using the results combined with culture and qPCR detection methods as the standard, the pathogen detection of BALF using nanopore sequencing had a sensitivity of 70% and a specificity of 91.7%. Additionally, the positive rate of the detection of M. tuberculosis using nanopore sequencing was 33.3% (6/18). The clinical medication plans of 74.3% (52/70) of the patients were referred to the nanopore sequencing results, of which 31 cases changed their treatment strategy, 21 supported the previous treatment plans, and 90% (47/52) of the patients finally had clinical improvement. Conclusions: BALF detection using nanopore sequencing technology improves the process of detecting pathogens in patients with LRTI, especially for M. tuberculosis, fungi, and viruses, by reducing the report time from three days to six hours. The clinical application prospect of nanopore sequencing technology is promising in the pathogen diagnosis of LRTI.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Extracellular HSP90a promotes cellular senescence in pulmonary fibrosis through TGFß signaling
Idiopathic pulmonary fibrosis (IPF) is a chronic age-related lung disease, in which cellular senescence have been proposed as an important pathogenesis. However, the mechanisms of fibroblast senescence remain unknown. We previously found that extracellular HSP90α(eHSP90α) promotes severe pulmonary fibrosis. We aimed to determine whether eHSP90α regulates cellular senescence and the impacts of 1G6-D7, anti-HSP90α monoclonal antibody, on pulmonary fibrosis development. We detected HSP90α in serum from IPF patients and healthy controls by ELISA. Bleomycin-induced lung fibrosis in wild-type and 1G6-D7 therapeutic treatment mice was measured by histology, collagen, profibrotic gene expression and pulmonary function testing. Cellular senescence was evaluated by senescence-associated β-galactosidase staining. RNA sequencing analysis was performed on IMR90 after F-5 fragment treatment, the functional fragment of eHSP90α.We found that serum HSP90α levels were elevated in IPF patients compared with healthy controls. α-sma, p16 and p21 expression, collagen deposition and resistance were decreased in 1G6-D7 therapeutic treatment mice. In vitro, F-5 fragment or recombinant HSP90α treatment in IMR90 increased cellular senescence. And 1G6-D7 reduced TGF-β1-induced cellular senescence. Notably, our RNA sequence analysis showed that TGFβ signaling was the most significant up-regulated signaling after F-5 fragment application. These data demonstrate that eHSP90α mediated cellular senescence to promote pulmonary fibrosis development, partially through TGFβ signaling. Therefore, targeting eHSP90α by 1G6-D7 to mitigate fibroblast senescence might be a prospective therapy to resolve pulmonary fibrosis.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Extracellular HSP90a promotes cellular senescence in pulmonary fibrosis through TGFß signaling
Idiopathic pulmonary fibrosis (IPF) is a chronic age-related lung disease, in which cellular senescence have been proposed as an important pathogenesis. However, the mechanisms of fibroblast senescence remain unknown. We previously found that extracellular HSP90α(eHSP90α) promotes severe pulmonary fibrosis. We aimed to determine whether eHSP90α regulates cellular senescence and the impacts of 1G6-D7, anti-HSP90α monoclonal antibody, on pulmonary fibrosis development. We detected HSP90α in serum from IPF patients and healthy controls by ELISA. Bleomycin-induced lung fibrosis in wild-type and 1G6-D7 therapeutic treatment mice was measured by histology, collagen, profibrotic gene expression and pulmonary function testing. Cellular senescence was evaluated by senescence-associated β-galactosidase staining. RNA sequencing analysis was performed on IMR90 after F-5 fragment treatment, the functional fragment of eHSP90α.We found that serum HSP90α levels were elevated in IPF patients compared with healthy controls. α-sma, p16 and p21 expression, collagen deposition and resistance were decreased in 1G6-D7 therapeutic treatment mice. In vitro, F-5 fragment or recombinant HSP90α treatment in IMR90 increased cellular senescence. And 1G6-D7 reduced TGF-β1-induced cellular senescence. Notably, our RNA sequence analysis showed that TGFβ signaling was the most significant up-regulated signaling after F-5 fragment application. These data demonstrate that eHSP90α mediated cellular senescence to promote pulmonary fibrosis development, partially through TGFβ signaling. Therefore, targeting eHSP90α by 1G6-D7 to mitigate fibroblast senescence might be a prospective therapy to resolve pulmonary fibrosis.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts
Activation of lung fibroblasts,which is the main source of extracellular matrix,plays a pivotal role in pulmonary fibrosis. Our previous study indicated that extracellular HSP90α is involved in the myofibroblast differentiation in pulmonary fibrosis. However extracellular HSP90α whether could modulate autophagy in pulmonary fibrosis remains unclearly. This study aimed to elucidate the extracellular HSP90α induced pulmonary fibrosis through regulating autophagy in lung fibroblasts. In vivo, we investigated the autophagy markers (LC3,P62 and Beclin1 ) as well as fibrosis-related markers through western blot and immunohistochemistry. In vitro, lung fibroblasts were treated with different concentrations of human recombinant HSP90α to examine the expression levels of α-SMA, collagen I and autophagy markers. What’s more, lung fibroblasts were transfected with siRNA to knock down P62 and Beclin1 and detected by western blot.We found that extracellular HSP90α could increase the expression of LC3, P62 and Beclin1. Consistently, 1G6-D7 could significantly decrease LC3,P62 and Beclin1 expression in vitro and in vivo. Furthermore, inhibiting P62 and Beclin1 by siRNA effectively reduced the expression of fibrosis-related markers induced by extracellular HSP90α.Taken together, this study indicated that extracellular HSP90α mediated the autophagic flux dysfunction in the lung fibroblasts through P62 and Beclin1. Our research highlights that extracellular HSP90α plays an important role in the development of pulmonary fibrosis, providing a new perspective for the diagnosis and treatment of pulmonary fibrosis.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts
Activation of lung fibroblasts,which is the main source of extracellular matrix,plays a pivotal role in pulmonary fibrosis. Our previous study indicated that extracellular HSP90α is involved in the myofibroblast differentiation in pulmonary fibrosis. However extracellular HSP90α whether could modulate autophagy in pulmonary fibrosis remains unclearly. This study aimed to elucidate the extracellular HSP90α induced pulmonary fibrosis through regulating autophagy in lung fibroblasts. In vivo, we investigated the autophagy markers (LC3,P62 and Beclin1 ) as well as fibrosis-related markers through western blot and immunohistochemistry. In vitro, lung fibroblasts were treated with different concentrations of human recombinant HSP90α to examine the expression levels of α-SMA, collagen I and autophagy markers. What’s more, lung fibroblasts were transfected with siRNA to knock down P62 and Beclin1 and detected by western blot.We found that extracellular HSP90α could increase the expression of LC3, P62 and Beclin1. Consistently, 1G6-D7 could significantly decrease LC3,P62 and Beclin1 expression in vitro and in vivo. Furthermore, inhibiting P62 and Beclin1 by siRNA effectively reduced the expression of fibrosis-related markers induced by extracellular HSP90α.Taken together, this study indicated that extracellular HSP90α mediated the autophagic flux dysfunction in the lung fibroblasts through P62 and Beclin1. Our research highlights that extracellular HSP90α plays an important role in the development of pulmonary fibrosis, providing a new perspective for the diagnosis and treatment of pulmonary fibrosis.
- 31 August 2020
- Published by Springer Nature in Quality of Life Research
- Vol. 30 (1) , 157-167
Belief in a just world, health-related quality of life, and mental health among Chinese patients with chronic obstructive pulmonary disease
Purpose Personal belief in a just world (PBJW) has been demonstrated to protect mental health. However, whether general belief in a just world (GBJW) serves adaptive functions for mental health across different groups and cultures remains unclear. This study explored the effects of PBJW and GBJW on mental health and moderating effects of PBJW and GBJW on the relation between health-related quality of life and mental health among patients with chronic obstructive pulmonary disease (COPD) in China. Methods A total of 147 patients with COPD (90.5% male; mean age = 64.44 years) completed measures of health-related quality of life, depression, anxiety, PBJW, and GBJW and provided pulmonary function data. Results Younger age and female sex were related to higher depression; female sex, living with others, and high financial burden were associated with higher anxiety. Worse health-related quality of life and lower PBJW were associated with higher depression and anxiety. An interaction between health-related quality of life and BJW was revealed. For patients with low PBJW, lower health-related quality of life was correlated with higher depression. For patients with stronger endorsement of GBJW, worse health-related quality of life was associated with higher depression and anxiety, but the variance of anxiety caused by interaction was insignificant. Conclusions The findings suggest that for patients with COPD experiencing health deterioration, holding strong PBJW but weak GBJW may be beneficial for mental health. Our study advances our understanding of the different functions of PBJW and GBJW in mental health across different groups and cultures.
- 31 August 2020
- Published by Springer Nature in Quality of Life Research
- Vol. 30 (1) , 157-167
Belief in a just world, health-related quality of life, and mental health among Chinese patients with chronic obstructive pulmonary disease
Purpose Personal belief in a just world (PBJW) has been demonstrated to protect mental health. However, whether general belief in a just world (GBJW) serves adaptive functions for mental health across different groups and cultures remains unclear. This study explored the effects of PBJW and GBJW on mental health and moderating effects of PBJW and GBJW on the relation between health-related quality of life and mental health among patients with chronic obstructive pulmonary disease (COPD) in China. Methods A total of 147 patients with COPD (90.5% male; mean age = 64.44 years) completed measures of health-related quality of life, depression, anxiety, PBJW, and GBJW and provided pulmonary function data. Results Younger age and female sex were related to higher depression; female sex, living with others, and high financial burden were associated with higher anxiety. Worse health-related quality of life and lower PBJW were associated with higher depression and anxiety. An interaction between health-related quality of life and BJW was revealed. For patients with low PBJW, lower health-related quality of life was correlated with higher depression. For patients with stronger endorsement of GBJW, worse health-related quality of life was associated with higher depression and anxiety, but the variance of anxiety caused by interaction was insignificant. Conclusions The findings suggest that for patients with COPD experiencing health deterioration, holding strong PBJW but weak GBJW may be beneficial for mental health. Our study advances our understanding of the different functions of PBJW and GBJW in mental health across different groups and cultures.
- Open Access
- 20 November 2019
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 19 (1) , 1-12
The role of secreted Hsp90α in HDM-induced asthmatic airway epithelial barrier dysfunction
Background: The dysfunction of airway epithelial barrier is closely related to the pathogenesis of asthma. Secreted Hsp90α participates in inflammation and Hsp90 inhibitor protects endothelial dysfunction. In the current study, we aimed to explore the role of secreted Hsp90α in asthmatic airway epithelial barrier function. Methods: Male BALB/c mice were sensitized and challenged with HDM to generate asthma model. The 16HBE and Hsp90α-knockdown cells were cultured and treated according to the experiment requirements. Transepithelial Electric Resistance (TEER) and permeability of epithelial layer in vitro, distribution and expression of junction proteins both in vivo and in vitro were used to evaluate the epithelial barrier function. Western Blot was used to evaluate the expression of junction proteins and phosphorylated AKT in cells and lung tissues while ELISA were used to evaluate the Hsp90α expression and cytokines release in the lung homogenate. Results: HDM resulted in a dysfunction of airway epithelial barrier both in vivo and in vitro, paralleled with the increased expression and release of Hsp90α. All of which were rescued in Hsp90α-knockdown cells or co-administration of 1G6-D7. Furthermore, either 1G6-D7 or PI3K inhibitor LY294002 suppressed the significant phosphorylation of AKT, which caused by secreted and recombinant Hsp90α, resulting in the restoration of epithelial barrier function. Conclusions: Secreted Hsp90α medicates HDM-induced asthmatic airway epithelial barrier dysfunction via PI3K/AKT pathway, indicating that anti-secreted Hsp90α therapy might be a potential treatment to asthma in future.
- 20 November 2019
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 19 (1) , 1-12
Open AccessThe role of secreted Hsp90α in HDM-induced asthmatic airway epithelial barrier dysfunction
Background: The dysfunction of airway epithelial barrier is closely related to the pathogenesis of asthma. Secreted Hsp90α participates in inflammation and Hsp90 inhibitor protects endothelial dysfunction. In the current study, we aimed to explore the role of secreted Hsp90α in asthmatic airway epithelial barrier function. Methods: Male BALB/c mice were sensitized and challenged with HDM to generate asthma model. The 16HBE and Hsp90α-knockdown cells were cultured and treated according to the experiment requirements. Transepithelial Electric Resistance (TEER) and permeability of epithelial layer in vitro, distribution and expression of junction proteins both in vivo and in vitro were used to evaluate the epithelial barrier function. Western Blot was used to evaluate the expression of junction proteins and phosphorylated AKT in cells and lung tissues while ELISA were used to evaluate the Hsp90α expression and cytokines release in the lung homogenate. Results: HDM resulted in a dysfunction of airway epithelial barrier both in vivo and in vitro, paralleled with the increased expression and release of Hsp90α. All of which were rescued in Hsp90α-knockdown cells or co-administration of 1G6-D7. Furthermore, either 1G6-D7 or PI3K inhibitor LY294002 suppressed the significant phosphorylation of AKT, which caused by secreted and recombinant Hsp90α, resulting in the restoration of epithelial barrier function. Conclusions: Secreted Hsp90α medicates HDM-induced asthmatic airway epithelial barrier dysfunction via PI3K/AKT pathway, indicating that anti-secreted Hsp90α therapy might be a potential treatment to asthma in future.
- 1 January 2019
- Vol. 9 (9) , 2047-+
The characterization of lung microbiome in lung cancer patients with different clinicopathology
There were few knowledge concerned correlation between lung microbiome and different clinicopathology of lung cancer. Bronchial washing fluid (BWF) and sputum are commonly used sample types but there was no study comparing difference of microbiome between these two in lung cancer. In this study, we aimed to compare difference of microbiome between these two sample types and characterize lung microbiome in squamous cell lung carcinoma with (SCC_M1) or without distant metastasis (SCC_M0) and lung adenocarcinoma with (AD_M1) or without distant metastasis (AD_M0). We collected 40 BWF samples and 52 sputum samples from newly diagnosed lung cancer patients. Bacterial species were sequenced via 16S rRNA sequencing. Phylum Proteobacteria in BWF samples were significantly higher than sputum samples (Wilcoxon test, P = 0.003). At phylum level, microbiome of BWF samples was more similar to that of lung cancer tissues reported in the previous literature. LEFse analysis showed that in BWF group, genera Veillonell, Megasphaera, Actinomyces and Arthrobacter in AD_M0 were significantly higher than those in SCC_M0, and genera Capnocytophaga and Rothia in AD_M1 were significantly lower than that in SCC_M1. Compared with AD_M0, genus Streptococcus of AD_M1 was significantly lower, and genera Veillonella and Rothia in SCC_M1 were significantly higher than that in SCC_M1. Our study suggested that BWF samples might better reflect the microbiome of lung cancer tissues. In different metastatic states of lung cancer, differential genera between squamous cell carcinoma and adenocarcinoma were different. And in different histologic types of lung cancer, distant metastasis-related genera were not the same.
- 1 January 2019
- Vol. 9 (9) , 2047-+
The characterization of lung microbiome in lung cancer patients with different clinicopathology
There were few knowledge concerned correlation between lung microbiome and different clinicopathology of lung cancer. Bronchial washing fluid (BWF) and sputum are commonly used sample types but there was no study comparing difference of microbiome between these two in lung cancer. In this study, we aimed to compare difference of microbiome between these two sample types and characterize lung microbiome in squamous cell lung carcinoma with (SCC_M1) or without distant metastasis (SCC_M0) and lung adenocarcinoma with (AD_M1) or without distant metastasis (AD_M0). We collected 40 BWF samples and 52 sputum samples from newly diagnosed lung cancer patients. Bacterial species were sequenced via 16S rRNA sequencing. Phylum Proteobacteria in BWF samples were significantly higher than sputum samples (Wilcoxon test, P = 0.003). At phylum level, microbiome of BWF samples was more similar to that of lung cancer tissues reported in the previous literature. LEFse analysis showed that in BWF group, genera Veillonell, Megasphaera, Actinomyces and Arthrobacter in AD_M0 were significantly higher than those in SCC_M0, and genera Capnocytophaga and Rothia in AD_M1 were significantly lower than that in SCC_M1. Compared with AD_M0, genus Streptococcus of AD_M1 was significantly lower, and genera Veillonella and Rothia in SCC_M1 were significantly higher than that in SCC_M1. Our study suggested that BWF samples might better reflect the microbiome of lung cancer tissues. In different metastatic states of lung cancer, differential genera between squamous cell carcinoma and adenocarcinoma were different. And in different histologic types of lung cancer, distant metastasis-related genera were not the same.
- 1 December 2018
- Published by Elsevier in Toxicology Letters
- Vol. 299, 149-158
RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model
- 1 December 2018
- Published by Elsevier in Toxicology Letters
- Vol. 299, 149-158
RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model